212 related articles for article (PubMed ID: 31728605)
1. The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.
Jansz TT; Goto NA; van Ballegooijen AJ; Willems HC; Verhaar MC; van Jaarsveld BC
Osteoporos Int; 2020 Mar; 31(3):515-524. PubMed ID: 31728605
[TBL] [Abstract][Full Text] [Related]
2. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for vertebral fractures in renal osteodystrophy.
Atsumi K; Kushida K; Yamazaki K; Shimizu S; Ohmura A; Inoue T
Am J Kidney Dis; 1999 Feb; 33(2):287-93. PubMed ID: 10023640
[TBL] [Abstract][Full Text] [Related]
4. Association of Trabecular Bone Score (TBS) With Incident Clinical and Radiographic Vertebral Fractures Adjusted for Lumbar Spine BMD in Older Men: A Prospective Cohort Study.
Schousboe JT; Vo TN; Langsetmo L; Taylor BC; Cawthon PM; Schwartz AV; Bauer DC; Orwoll ES; Lane NE; Barrett-Connor E; Ensrud KE;
J Bone Miner Res; 2017 Jul; 32(7):1554-1558. PubMed ID: 28300346
[TBL] [Abstract][Full Text] [Related]
5. Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
Chen H; Lips P; Vervloet MG; van Schoor NM; de Jongh RT
Osteoporos Int; 2018 Sep; 29(9):2129-2138. PubMed ID: 29947873
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
[TBL] [Abstract][Full Text] [Related]
7. The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
Aleksova J; Kurniawan S; Elder GJ
Osteoporos Int; 2018 Jun; 29(6):1447-1455. PubMed ID: 29556678
[TBL] [Abstract][Full Text] [Related]
8. Influence of vitamin D status on vertebral fractures, bone mineral density, and bone turnover markers in normocalcemic postmenopausal women with high parathyroid hormone levels.
Hernández JL; Olmos JM; Pariente E; Nan D; Martínez J; Llorca J; Valero C; Obregón E; González-Macías J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1711-7. PubMed ID: 23457409
[TBL] [Abstract][Full Text] [Related]
9. The relationship between bone density and incident vertebral fracture in men and women.
J Bone Miner Res; 2002 Dec; 17(12):2214-21. PubMed ID: 12469915
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
11. Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
Watanabe R; Tai N; Hirano J; Ban Y; Inoue D; Okazaki R
Osteoporos Int; 2018 Mar; 29(3):615-623. PubMed ID: 29167970
[TBL] [Abstract][Full Text] [Related]
12. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture.
Schousboe JT; Fink HA; Lui LY; Taylor BC; Ensrud KE
J Bone Miner Res; 2006 Oct; 21(10):1557-64. PubMed ID: 16995810
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density.
Mitra D; Elvins DM; Speden DJ; Collins AJ
Rheumatology (Oxford); 2000 Jan; 39(1):85-9. PubMed ID: 10662879
[TBL] [Abstract][Full Text] [Related]
14. Incident vertebral fracture and longitudinal BMD change in Chinese postmenopausal women with early CKD: Peking Vertebral Fracture Study.
Jiajue R; Liang H; Jiang Y; Cui L; Pang Q; Chi Y; Liu W; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Arch Osteoporos; 2023 Sep; 18(1):116. PubMed ID: 37697181
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
[TBL] [Abstract][Full Text] [Related]
16. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis.
Legrand E; Chappard D; Pascaretti C; Duquenne M; Krebs S; Rohmer V; Basle MF; Audran M
J Bone Miner Res; 2000 Jan; 15(1):13-9. PubMed ID: 10646109
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures.
Nevitt MC; Cummings SR; Stone KL; Palermo L; Black DM; Bauer DC; Genant HK; Hochberg MC; Ensrud KE; Hillier TA; Cauley JA
J Bone Miner Res; 2005 Jan; 20(1):131-40. PubMed ID: 15619679
[TBL] [Abstract][Full Text] [Related]
18. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
Rehman Q; Lang T; Modin G; Lane NE
Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
